Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study.

Priya PatelSara R LavoratoreJacqueline FlankMeaghan KempAshlee VennettilliHelen VolTracey TaylorElyse ZelunkaAnne Marie MaloneyPaul C NathanL Lee Dupuis

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)

Our findings support the classification of etoposide 100 mg/m2/day plus ifosfamide 1800 mg/m2/day IV over 5 days as highly emetogenic. This information will optimize antiemetic prophylaxis selection and CINV control in pediatric patients.

Keyphrases

chemotherapy induced
machine learning
deep learning
healthcare
health information
social media